| EPE424 | Circumventing the impact of COVID-19 pandemic on access to HIV-1 RNA assay in Nigeria | E-poster | Optimizing HIV services (prevention, testing and/or treatment) in the COVID-19 era |
| EPE423 | Brazilian Ministry of Health strategies to address disruptions to HIV testing during COVID-19 pandemic | E-poster | Optimizing HIV services (prevention, testing and/or treatment) in the COVID-19 era |
| EPE422 | Training adaptations to address quality improvement in PEPFAR-supported Latin America programs in the era of COVID-19 | E-poster | Optimizing HIV services (prevention, testing and/or treatment) in the COVID-19 era |
| EPE421 | Responding to the COVID-19 pandemic: HIV continuing professional development virtual seminars for healthcare workers in Ukraine | E-poster | Optimizing HIV services (prevention, testing and/or treatment) in the COVID-19 era |
| EPE420 | COVID-19, telehealth and HIV care | E-poster | Optimizing HIV services (prevention, testing and/or treatment) in the COVID-19 era |
| EPE419 | A qualitative study of patient and provider experiences with telemedicine for HIV care | E-poster | Optimizing HIV services (prevention, testing and/or treatment) in the COVID-19 era |
| EPE418 | Effects of COVID-19 on HIV Financing Prospects in 15 Asian Countries | E-poster | Impact of COVID-19 on financing for the HIV response |
| EPE417 | A pandemic triad: HIV, COVID-19 and debt in developing countries | E-poster | Impact of COVID-19 on financing for the HIV response |
| EPE416 | Revisiting sustainable financing for the HIV/AIDS response in the COVID-19 era | E-poster | Impact of COVID-19 on financing for the HIV response |
| EPE415 | Acceleration ofthe implementation of differentiated ART delivery services in the advent of COVID-19 in Zambia | E-poster | Impact of COVID-19 on HIV treatment services |